For Founders
Investor database
Access the ultimate investor list with 12,000+ VCs, angels, and more.
Fundraising CRM
Keep your raise organized with a smart CRM that keeps you on track.
Pitch deck tracking
Securely share, track & manage your pitch deck with investors
For Investors
Startup deal flow
Access top 1% rounds before they close - no commission, no equity.
LP database
Search our private base of 10,000+ HNWI, FoF, FOs, and more
LP/GP Events
Meet your next LPs at 400+ curated events
All investor lists > Boston
Browse OpenVC's list of VC firms, angel investors, and accelerators in Boston. From pre-seed, seed, Series A, and beyond—find opportunities to raise capital for your startup.
Last update: June 15, 2026
List author: Devon Wood
Shortlist investors, submit pitch decks, and get replies
Use code "OpenVC". Conditions apply.
The Boston venture capital scene is one of the most dynamic and unique ecosystems in the world. Known as the biotech capital globally and a deeptech stronghold, Boston also fosters a thriving SaaS environment. With its proximity to world-class universities like MIT and Harvard, leading research institutions, and a robust network of established corporations, Boston offers a wealth of resources for startups at every stage.
Whether you’re launching your first deeptech venture, scaling an innovative SaaS product, or seeking funding for your biotech startup, this blog will walk you through Boston’s VC scene, including the top VC firms in Boston, its most popular industries for startups, and the fundraising playbook you need to succeed.
Boston’s reputation as a global leader in venture capital is backed by its strong focus on innovation, with deep ties to healthcare and technology. Boasting some of the most prestigious academic and research institutions in the world, Boston’s entrepreneurial ecosystem thrives on knowledge exchange and cutting-edge developments.
While its biotech and life sciences sectors are internationally recognized, the city has also established itself as a hub for deeptech startups focused on AI and robotics. Meanwhile, enterprise software continues to flourish, supported by Boston's dense population of forward-thinking corporations.
New England VC firms offer not just financial backing but also credibility and access to critical infrastructure. Many venture firms work closely with institutional players like hospital systems, pharma giants, and esteemed universities to provide startups with invaluable operational insight and strategic opportunities.
Boston’s VC ecosystem is highly clustered by neighborhood, and it maps closely to the city’s academic and biotech hubs:
Notable VCs in this area: Flagship Pioneering, Third Rock Ventures, Atlas Venture, RA Capital, F-Prime Capital.
Notable VCs in this area: Battery Ventures, General Catalyst, Bain Capital Ventures
Boston is not a generalist startup city. Capital here clusters around sectors with deep institutional gravity. If you’re building in Boston, you’re usually plugged into one of these engines.
Boston’s life sciences ecosystem is anchored in Cambridge’s Kendall Square, often cited as one of the densest biotech clusters globally. Within a few blocks you’ll find MIT, the Broad Institute, Moderna’s headquarters, and multiple venture-backed labs.
Firms like Flagship Pioneering, Third Rock Ventures, Atlas Venture, and RA Capital don’t just fund biotech — they help create companies from scientific discovery. LabCentral and MassBio serve as early physical infrastructure for spinouts, while the Massachusetts Life Sciences Center provides grants and tax incentives to support early development.
If you’re building therapeutics, platform biology, genomics, or computational drug discovery, Boston has a structured path from lab to venture funding that few cities can match.
Boston is one of the few cities where hardware, robotics, advanced materials, and energy startups can raise institutional venture capital at the seed stage.
MIT’s CSAIL and engineering departments generate a steady stream of spinouts. The Engine, founded by MIT, was created specifically to fund “tough tech” companies that require longer development timelines and significant capital intensity.
Greentown Labs in Somerville supports climate and hardware founders with shared lab space, and many early-stage companies layer in SBIR and ARPA-E grants before or alongside venture funding.
This is a capital stack city. Non-dilutive funding and research partnerships often precede priced rounds.
Few regions offer the same proximity to hospital systems as Boston. Mass General Brigham, Dana-Farber Cancer Institute, and Boston Children’s Hospital all operate innovation arms and frequently collaborate with venture-backed startups.
Digital health companies here often secure clinical validation partnerships early. Venture firms like F-Prime Capital and Polaris Partners are active in healthcare and frequently co-invest alongside institutional or corporate capital.
For founders building in care delivery, medical software, diagnostics, or healthcare AI, the advantage in Boston is access to live clinical environments and strategic hospital partnerships.
Boston’s SaaS ecosystem grew out of companies like HubSpot, Wayfair, Rapid7, and Toast. The alumni network from these companies continues to seed new startups, particularly in enterprise tooling and vertical software.
Battery Ventures, General Catalyst, Accomplice, and OpenView Venture Partners have long histories of backing B2B software companies at seed through growth.
Unlike Silicon Valley’s consumer-heavy cycles, Boston SaaS tends to skew enterprise-first, metrics-driven, and operationally focused.
If your product solves workflow or infrastructure problems for businesses, you’ll find experienced operators and capital partners here who understand recurring revenue models.
Massachusetts has made climate policy and clean energy a priority at the state level, and that shows up in startup activity.
The Massachusetts Clean Energy Center (MassCEC) provides grants and early support. Greentown Labs acts as a physical hub for climate hardware startups. The Engine invests in long-horizon energy and materials innovation.
Boston’s climate ecosystem blends academic research, state funding, and early-stage venture in a way that supports technologies that may take years to commercialize.
Boston venture capital firms tend to underwrite risk differently than their counterparts in faster-moving markets. Technical credibility carries real weight here, particularly for early-stage venture capital backing healthcare companies, biotech, and complex software platforms.
That doesn’t mean polish doesn’t matter—but substance comes first. Investors want to see founders who deeply understand their market, their customers, and the constraints of their industry. Whether it’s clinical validation, early customer adoption, or clear technical milestones, evidence matters more than storytelling.
Teams matter too, but not in a formulaic way. Boston-based firms often back entrepreneurs with academic, research, or operator backgrounds (especially when there’s a strong “why now” behind the company). Many deals still originate through trusted networks: former founders, advisors, or operators connected to prior portfolio companies.
OpenVC makes these dynamics visible before the first email goes out. By exploring investor portfolios, sector focus, and stage preferences in one place, founders can align their story with what Boston venture capital firms actually look for, rather than guessing.
Here are some of the leading Boston venture capital firms you need to know when raising funds in The Hub. From biotech to SaaS, these firms specialize in sectors that have helped shape the city’s innovative scene.
Works at the nexus of biotech and innovation, transforming scientific insights into impactful companies.
Flagship Pioneering operates less like a traditional VC firm and more like a venture creation engine. A large portion of its companies are incubated internally, often built around scientific hypotheses generated within its own research teams rather than sourced through inbound founder pitches.
Moderna is the most prominent outcome of that model. Flagship has repeatedly built platform biology companies from scratch, committing foundational capital before bringing in outside investors.
Because of this structure, Flagship is deeply embedded in Boston’s biotech formation layer. For external founders, raising from Flagship typically means aligning with their platform-driven, science-first approach rather than pitching a conventional seed-stage startup.
A pioneer in scaling high-growth companies across various sectors.
General Catalyst is one of Boston’s most influential multi-stage firms. Unlike highly specialized biotech funds in Cambridge, GC operates across software, fintech, healthcare, and consumer, with offices beyond Boston including San Francisco and New York.
The firm is known for leading rounds from early stage through growth, often maintaining long-term positions in breakout companies. It has backed businesses such as HubSpot, Stripe, Snap, and Airbnb, giving it credibility across both enterprise and consumer markets.
In Boston specifically, General Catalyst plays a central role in SaaS and digital health rounds. It frequently co-invests with coastal firms and has the balance sheet to support companies well beyond Series A, which makes it a common anchor investor for founders building category-scale software companies.
Specializes in creating and investing in transformational biotech companies that redefine medicine.
Third Rock Ventures is known for building biotech companies from inception, often assembling founding teams around scientific discoveries rather than backing fully formed startups. The firm takes an active role in shaping strategy, leadership, and early capital formation.
Unlike diversified multi-stage funds, Third Rock is tightly focused on life sciences. It frequently syndicates with other Cambridge-based biotech investors and has a track record of taking companies public or through major acquisitions.
In Boston’s biotech corridor, Third Rock operates as both investor and architect, particularly for companies grounded in translational medicine and genomic science.
Backs emerging companies across SaaS, infrastructure, and more.
Battery Ventures is one of the longest-standing venture firms with a significant Boston presence. It operates across early-stage and growth equity, which gives it flexibility to lead Series A rounds and continue deploying capital through expansion stages.
The firm has backed major enterprise and cloud software companies globally. In Boston, Battery plays a central role in SaaS and infrastructure funding, often anchoring later-stage rounds for companies that have established repeatable revenue.
Unlike biotech-heavy Cambridge funds, Battery represents the more enterprise-focused side of Boston venture capital.
Anchored in biotech, building category-leading companies from the ground up.
Atlas Venture concentrates almost exclusively on biotech company creation. The firm is known for forming companies around drug development platforms and recruiting experienced executives early in the lifecycle.
Atlas typically leads seed rounds in therapeutics and remains closely involved through clinical milestones. Its strategy centers on building focused, capital-efficient biotech companies rather than broad platform plays.
Within Kendall Square, Atlas is considered one of the core early-stage biotech investors alongside Third Rock and Flagship.
“Tough tech” that tackles world-changing problems while spinning out from MIT and other academic centers.
The Engine was founded by MIT to support “tough tech” companies working on scientific and engineering breakthroughs that require longer development cycles.
Beyond capital, The Engine operates physical lab and office space in Cambridge designed for hardware and advanced research companies. This infrastructure component distinguishes it from traditional venture firms.
The Engine frequently backs robotics, advanced materials, energy systems, and other capital-intensive technologies emerging from academic research.
Experts in product-led growth, OpenView invests heavily in scaling SaaS companies.
OpenView is known for its focus on product-led growth (PLG) software companies. The firm concentrates on expansion-stage SaaS, typically investing after companies have demonstrated strong user acquisition and revenue traction.
Rather than broad sector coverage, OpenView’s thesis centers on scaling software businesses that rely on bottom-up adoption models.
In Boston’s ecosystem, OpenView represents the growth-stage SaaS layer, distinct from seed-focused firms.
A prominent player in biotech and healthcare sectors with a focus on innovation.
F-Prime Capital is affiliated with Fidelity Investments, which gives it deep institutional backing. The firm invests across healthcare, life sciences, and financial technology.
Its healthcare investments often intersect with Boston’s hospital systems and biotech research institutions. F-Prime participates from early seed through Series B and frequently syndicates with other major healthcare investors.
The Fidelity connection also positions F-Prime uniquely in fintech and enterprise financial services investments.
Flexible and founder-focused, this firm takes pride in supporting early-stage innovators across diverse sectors.
Accomplice focuses primarily on early-stage software companies, particularly in SaaS and cybersecurity. The firm often acts as a lead investor in seed and Series A rounds.
In addition to direct investments, Accomplice has launched sidecar and angel network initiatives that expand its early-stage reach.
Within Boston’s venture landscape, Accomplice plays a visible role in backing technical founders building enterprise-focused products.
Target high-impact sectors including clean tech and IT software.
MassVentures is a state-backed venture capital firm focused exclusively on Massachusetts-based startups. It operates with a public mission to support high-impact technology companies in the region.
The firm often invests at the seed stage and works closely with state grant programs and economic development initiatives.
For founders building in Massachusetts, MassVentures represents one of the more accessible institutional capital sources aligned with local growth.
Early-stage investor at the intersection of healthcare, life sciences, and technology.
Polaris Partners has long been active in both healthcare and enterprise software. The firm frequently leads early-stage rounds and maintains a strong presence in Boston’s life sciences ecosystem.
Polaris has backed companies across therapeutics, medical devices, and software infrastructure. It often works closely with management teams through product-market fit and early commercialization phases.
Within Boston, Polaris sits at the intersection of healthcare and technology investing, bridging two of the region’s dominant sectors.
One of Boston’s standout features is the close collaboration between VCs, large institutions, and corporates. Hospital innovation funds, biotech partners, and even university endowments frequently co-invest with major VC firms. This synergy provides startups with more than just funding; it unlocks unparalleled access to state-of-the-art infrastructure, credibility, and operational expertise.
For example, corporate VC arms of global pharma companies often participate in biotech fundraising, ensuring both funding and strategic industry ties. Similarly, hospital systems provide medtech startups with on-the-ground validation and a pathway to market adoption.
Boston is more than just a hub for venture capital firms. The city also offers a dense network of programs, accelerators, and organizations that can make or break your fundraising journey. If you’re building a startup in Boston, here are some of the best local resources to know:
MassChallenge – One of the largest startup accelerators in the world, offering equity-free support, mentorship, and exposure to top investors.
Techstars Boston – Provides funding, mentorship, and a strong investor network, with a long track record of scaling successful Boston startups.
The Engine – Founded by MIT, this incubator focuses on “tough tech” startups in biotech, climate, and advanced engineering.
MIT Sandbox Innovation Fund Program – Provides early-stage funding and mentorship for MIT-affiliated founders.
Harvard Innovation Labs (i-Lab) – Offers workspace, mentorship, and venture competitions for Harvard students and alumni.
Northeastern IDEA – A student-run venture accelerator that provides non-equity funding and coaching.
MassVentures – A state-backed VC firm focused on early-stage, Massachusetts-based tech and life sciences startups.
Massachusetts Life Sciences Center (MLSC) – Provides grants, tax incentives, and funding programs for life sciences startups.
MassCEC (Clean Energy Center) – Supports clean energy and climate tech ventures through grants and pilot funding programs.
Raising capital in Boston is less about momentum and more about conviction. The city’s venture capital ecosystem is dense, analytical, and deeply influenced by academia, healthcare, and long-term technology bets. For an entrepreneur, that means early conversations tend to move more slowly. But when an investment comes together, it’s usually anchored by real belief in the business.
At the early-stage venture level, most rounds are led by a Boston-based venture capital fund with strong local roots. Firms like Polaris Partners, Pillar VC, and Underscore VC often act as the first institutional capital partner, especially for technology companies building in healthcare, deeptech, or enterprise software. These funds don’t just provide capital—they help shape the company through early hires, strategic partnerships, and follow-on support.
Boston investors also think in systems. Portfolio construction matters, and many firms are intentional about how new investments fit alongside existing portfolio companies. As traction builds, it’s common for a local venture fund to bring in out-of-region investors or growth equity capital to support the next phase of scale.
OpenVC helps founders approach this process with focus. Instead of pitching every venture capital fund in the region, you can identify investors based in Boston, see how their portfolios are actually structured, and target capital partners who actively invest at your stage. That clarity saves time—and helps founders move conversations forward with confidence.
Want to expand your investor search beyond Boston’s city limits? Check out these other pre-built investor lists.
By location
By Industry
Whether you’re building the next SaaS unicorn or redefining life sciences innovation, Boston is brimming with opportunities to secure startup funding.
Use OpenVC to streamline your search for the perfect Boston VC. Find aligned investors, pitch smarter, and manage your fundraising process all in one place.
👉 Start your raise today
Save investors, manage outreach, and run your fundraising in one platform.
OpenVC is a free startup fundraising platform that helps founders find the right investors and manage their entire raise. Search 20,000+ verified investors, including venture capitalists, angel investors, family offices, accelerators, and more. Build your target list, send your pitch deck, and track your pipeline all in one place.
Founders raise with OpenVC because it is designed to cut through the noise and get founders in front of the right investors, fast. With built-in tools for CRM, analytics, and warm intros, it helps you stay organized and improve your chances of getting a reply.
OpenVC is for early-stage startup founders who want to raise capital efficiently. Find investors from dozens of industries including SaaS, AI, fintech, biotech, and more. Whether you’re pre-seed, seed, or Series A, OpenVC helps you find and pitch aligned investors without paying intro fees, aimlessly cold-emailing, or scraping databases.
To start pitching investors on OpenVC, create a free account and submit your pitch deck directly through our startup funding platform. Investors receive a unique link to view your deck, and you get analytics on who opens it and how long they spend on it. No cold emails, no guesswork. For more info, check out our complete guide to fundraising on OpenVC.
Absolutely, OpenVC is designed for early-stage fundraising. You’ll find thousands of angel investors, pre-seed VCs, accelerators, incubators, and family offices who are actively backing startups across sectors and geographies. Use OpenVC’s filters to narrow your search and find the right investors for your startup.
Some examples of startups that successfully secured funding through OpenVC include Mobly (2.5M seed), Paxum ($1.2M seed), and Laennec AI ($400k pre-seed). OpenVC startups have gone on to raise more than $1 billion from top venture capital firms like YC, Sequoia, Google Ventures, and M12.
OpenVC was created by Stephane Nasser and Lucas Roquilly—two founders building tools to make startup fundraising more transparent and accessible. We launched OpenVC to help founders find investors, get replies, and raise smarter. The platform is bootstrapped, community-driven, and built with a lot of heart.
Are you a VC firm, angel, or accelerator?
Join OpenVC's database to increase your visibility with startup founders, or update your profile to keep your information current.